These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25012937)

  • 1. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
    Ganai SA; Kalladi SM; Mahadevan V
    J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D; Lampen A; Nau H
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
    Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
    Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
    Milutinovic S; D'Alessio AC; Detich N; Szyf M
    Carcinogenesis; 2007 Mar; 28(3):560-71. PubMed ID: 17012225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
    Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms.
    Ganai SA; Shanmugam K; Mahadevan V
    J Biomol Struct Dyn; 2015; 33(2):374-87. PubMed ID: 24460542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the valproic acid binding site on histone deacetylase 8 using docking and molecular dynamic simulations.
    Bermúdez-Lugo JA; Perez-Gonzalez O; Rosales-Hernández MC; Ilizaliturri-Flores I; Trujillo-Ferrara J; Correa-Basurto J
    J Mol Model; 2012 Jun; 18(6):2301-10. PubMed ID: 21968575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.
    Sixto-López Y; Bello M; Correa-Basurto J
    J Comput Aided Mol Des; 2020 Aug; 34(8):857-878. PubMed ID: 32180123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
    Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
    PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β.
    Correa F; Mallard C; Nilsson M; Sandberg M
    Neurobiol Dis; 2011 Oct; 44(1):142-51. PubMed ID: 21757005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
    Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
    J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
    Khan S; Jena G; Tikoo K
    Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of antiepileptic drugs as histone deacetylase inhibitors.
    Eyal S; Yagen B; Sobol E; Altschuler Y; Shmuel M; Bialer M
    Epilepsia; 2004 Jul; 45(7):737-44. PubMed ID: 15230695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.